Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
URMC / Research / Clinical Trials / Study Details

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Research Question:
Does the drug Baricitinib help people with alopecia areata?

Basic Study Information

This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the treatment of severe or very severe alopecia areata.

Location: University of Rochester School of Medicine
Study Reference #: NA9

Lead Researcher (Principal Investigator)

Lead Researcher:  Mary Gail Mercurio

Study Contact Information

Study Coordinator: Jean Sauvain
Phone: (585) 273-4421

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search